MMedication Read More Hims & Hers announces Wegovy pill copy; Novo Nordisk vows legal actionFebruary 6, 2026 The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark,…
HHealthcare Read More Pfizer’s monthly obesity injection drove shows promise in trialFebruary 3, 2026 Smith Collection | Archive Photos | Getty Images Pfizer on Thursday said its experimental obesity drug, which it…
HHealthcare Read More Eli Lilly CEO David Ricks talks Medicare coverage of obesity pillsJanuary 30, 2026 Eli Lilly CEO Dave Ricks on Friday said upcoming Medicare coverage of obesity drugs could be a major…
HHealthcare Read More Eli Lilly plans $3.5 billion Pennsylvania plant for obesity drugsJanuary 30, 2026 Eli Lilly Chair and CEO Dave Ricks speaks during a press conference in Houston, Sept. 23, 2025. Antranik…
HHealthcare Read More Next steps for Eli Lilly, Novo Nordisk, PfizerJanuary 23, 2026 A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, Jan. 15, 2026. George…
HHealthcare Read More Novo Nordisk shares rise after Wegovy obesity pill launchJanuary 16, 2026 A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, US, on Thursday, Jan.…
HHealthcare Read More Eli Lilly investors shouldn’t sweat rival Novo Nordisk having the first obesity pill on saleDecember 23, 2025 Jim Cramer says don’t sweat Novo Nordisk’s head start over Club holding Eli Lilly in the obesity pill…
HHealthcare Read More Obesity pills from Novo Nordisk, Eli Lilly are comingDecember 16, 2025 Daniel Grill | Tetra Images | Getty Images A version of this article first appeared in CNBC’s Healthy…
HHealthcare Read More WHO backs use of GLP-1 therapies for obesity, warns access will remain limitedDecember 2, 2025 A view shows The World Health Organization (WHO) headquarters in Geneva, Switzerland, Jan. 28, 2025. Denis Balibouse |…
HHealthcare Read More Novo Nordisk stumbles against Eli Lilly in GLP-1 drug battle. Which stock is best?November 24, 2025 In the battle between weight-loss drug companies, Eli Lilly has emerged as the clear winner for investors. The…
AArtificial intelligence Read More Markets could face ‘everything bubble’ as selloff rages onNovember 24, 2025 Global stocks have fluctuated wildly over the past week, as concerns about AI valuations hang over equity markets.…
HHealthcare Read More Eli Lilly hits $1 trillion market value, first for health care companyNovember 21, 2025 A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March…